STAAR Surgical CompanySTAAR Surgical CompanySTAAR Surgical Company

STAAR Surgical Company

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.14 B‬EUR
−1.64EUR
‪−19.52 M‬EUR
‪303.22 M‬EUR
‪49.39 M‬
Beta (1Y)
1.20
Employees (FY)
‪1.21 K‬
Change (1Y)
+96 +8.61%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About STAAR Surgical Company


CEO
Stephen C. Farrell
Website
Headquarters
Lake Forest
Founded
1982
ISIN
US8523123052
FIGI
BBG000GMV605
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Check out other big names from the same industry as SR3.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange STAAR Surgical Company stocks are traded under the ticker SR3.
We've gathered analysts' opinions on STAAR Surgical Company future price: according to them, SR3 price has a max estimate of 24.01 EUR and a min estimate of 13.72 EUR. Watch SR3 chart and read a more detailed STAAR Surgical Company stock forecast: see what analysts think of STAAR Surgical Company and suggest that you do with its stocks.
SR3 reached its all-time high on Sep 8, 2021 with the price of 137.30 EUR, and its all-time low was 0.59 EUR and was reached on May 4, 2009. View more price dynamics on SR3 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track STAAR Surgical Company financials in yearly and quarterly reports right on TradingView.
STAAR Surgical Company is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
SR3 earnings for the last quarter are −0.29 EUR per share, whereas the estimation was −0.48 EUR resulting in a 39.48% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about STAAR Surgical Company earnings.
STAAR Surgical Company revenue for the last quarter amounts to ‪37.62 M‬ EUR, despite the estimated figure of ‪34.38 M‬ EUR. In the next quarter, revenue is expected to reach ‪79.45 M‬ EUR.
SR3 net income for the last quarter is ‪−14.27 M‬ EUR, while the quarter before that showed ‪−50.11 M‬ EUR of net income which accounts for 71.52% change. Track more STAAR Surgical Company financial stats to get the full picture.
No, SR3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has ‪1.21 K‬ employees. See our rating of the largest employees — is STAAR Surgical Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAAR Surgical Company EBITDA is ‪−81.41 M‬ EUR, and current EBITDA margin is −1.82%. See more stats in STAAR Surgical Company financial statements.
Like other stocks, SR3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAAR Surgical Company stock right from TradingView charts — choose your broker and connect to your account.